CDK2 and breast carcinoma: Earlier studies that showed functional ablation of retinoblastoma protein (pRb) leads to activation of CDK2 in breast cancer [15,50] and concordantly, that deregulation of E2F transcription factor target genes associated with poor prognosis [51].